HOME >> MEDICINE >> NEWS
Have the police hijacked our DNA?

Creating a DNA database of all UK men to assist in criminal investigations may sound extreme; however this week's editorial proposes that there has been no more rational option to date in an attempt to use DNA profiling to assist in the identification of violent offenders in the UK, 80% of whom are men.

The over-reliance by police and governments on DNA fingerprinting is discussed: 'the use of DNA evidence in criminal cases, in particular the use of so-called cold hits to identify perpetrators, is worrisome.

This technique involves attempting to match a DNA profile obtained from a crime scene against a DNA database. Police forces across the world claim that this technique has allowed them to solve many cases, some years old.

In New York City police are going one step further. To prevent sex-offenders from using the statute of limitations to escape prosecution, where no match can be made to a person, the DNA itself will be charged with the offence. But this approach ignores the fundamental reason for a statute of limitations-in very old cases it is hard for defendants to defend themselves properly.'

The matching of an individual's DNA to that of DNA recovered from a crime scene does not necessarily mean that that person is the criminal: 'First, a DNA profile can be generated from very few cells that can be left by innocent means-the amount left on a drinking glass or a door handle. Second, although the number of DNA repeats used to compare profiles means it is very unlikely that any two individuals will have the same profile, it is not impossible. Third, at least in the USA, the standard of work in many laboratories that handle DNA evidence is not consistent; despite several cases where laboratories mishandled DNA evidence only three states, New York, Oklahoma, and Texas require accreditation to specified standards.'

The editorial concludes by discussing whose DNA should most usefully be available from national DNA databases
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
18-Sep-2003


Page: 1 2

Related medicine news :

1. Training could remove racial bias from police reactions
2. Tight rules, police presence may limit use of Vancouvers new drug injection facility
3. Armed with AEDs, police save lives by cutting response time

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Have the police hijacked our DNA

(Date:5/21/2013)... Diversity Focus, a non-profit organization striving to improve the ... Creative Corridor region, is releasing results for its 2013 ... Thursday, May 23rd at 10:30 a.m. The survey ... , The survey is a critical component to the ... nurture and retain people of diverse backgrounds, cultures and ...
(Date:5/21/2013)... AURORA, Colo. (May 21, 2013) A paper recently ... and co-written by physicians and scientists at the ... important genetic risk factor for pulmonary fibrosis can be ... lung disease. , Researchers looked at a fairly common ... is a component of the mucous produced by the ...
(Date:5/21/2013)... and technological research So Paulo Research Foundation, FAPESP, based ... estimated in US$ 680 million to support 17 Research, ... up to eleven years, subject to continuation reviews on ... the 17 RIDCs will come from FAPESP and the ... infrastructure). Host institutions will participate in a portion of ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Today, Zane ... HSA and FSA accounts. Zane Benefits, which provides ... benefits, is the leader in defined contribution ... arrangements . , According to Zane Benefits’ website, the ... was signed into law in 2010 and impacts many ...
(Date:5/21/2013)... 2013 While North Carolina is synonymous ... travel guides. Brunswick Plantation & Golf Resort is synonymous ... access to 27 holes of "Top10" championship golf. ... Carolina, knowing the Top 10 from an ... the overwhelming task of selecting the course to play. ...
Breaking Medicine News(10 mins):Health News:Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m. 2Health News:Researchers find genetic risk factor for pulmonary fibrosis 2Health News:Research at the cutting edge of knowledge 2Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 2Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 3Health News:Brunswick Plantation & Golf Resort Named in Top 10 Golf Resorts in North Carolina 2
(Date:5/21/2013)... ALLENTOWN, Pa. , May 21, 2013  Lehigh ... additional TRU-D SmartUVC TM devices, adding to its ... With seven devices taking up residence within the network, ... in the U.S. to proactively combat superbugs and provide ... Short for Total Room Ultraviolet Disinfector, TRU-D – the ...
(Date:5/21/2013)... , May 21, 2013 Sanofi (EURONEXT: ... REGN) today announced that the New England Journal ... study results of dupilumab (SAR231893/REGN668) in patients with moderate-to-severe ... the alpha subunit of the interleukin 4 receptor (IL-4R ... drivers of Th2 (Type 2 helper T cell) immune ...
(Date:5/21/2013)... 2013 Abaxis, Inc. (NasdaqGS: ABAX), a medical ... that Martin Mulroy , chief commercial ... & Veterinary Conference on Wednesday, May 29, 2013 at ... Le Parker Meridien Hotel in New York ... Abaxis develops, manufactures, markets and sells portable blood analysis ...
Breaking Medicine Technology:Lehigh Valley Expands Fleet of Superbug-Slaying Robots 2Lehigh Valley Expands Fleet of Superbug-Slaying Robots 3Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 2Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 3Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 4Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 5Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 6Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 7Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2
Cached News: